Predicting Drug Sales: Pfizer's Post-Revenue Assets in the Spotlight
Accurately estimating the future sales of drugs that are already on the market, known as post-revenue assets, is a big deal in the pharmaceutical world. It helps companies like Pfizer make smart decisions about where to invest their money. This study introduces a new way to forecast these sales by u